| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/17/2004 | US20040112832 Purification of polypeptides; elimination Moraxella |
| 06/17/2004 | CA2836951A1 Prion protein ligands and methods of use |
| 06/17/2004 | CA2508765A1 Bone growth factor |
| 06/17/2004 | CA2508539A1 Gp120 specific antigens and uses thereof |
| 06/17/2004 | CA2508519A1 Recombinant immunotoxin and use in treating tumors |
| 06/17/2004 | CA2508378A1 Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making |
| 06/17/2004 | CA2508302A1 Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 06/17/2004 | CA2508232A1 Protein binding to akt2 |
| 06/17/2004 | CA2508221A1 Recombinant polypeptides for diagnosing infection with trypanosoma cruzi |
| 06/17/2004 | CA2507990A1 Novel ifngamma-like polypeptides |
| 06/17/2004 | CA2507936A1 Prion protein ligands and methods of use |
| 06/17/2004 | CA2507709A1 Therapeutic and diagnostic agents |
| 06/17/2004 | CA2507631A1 Splice variant of the human pituitary growth hormone |
| 06/17/2004 | CA2507494A1 Rationally designed antibodies |
| 06/17/2004 | CA2507403A1 Ciz1 splice variants |
| 06/17/2004 | CA2505583A1 Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods |
| 06/17/2004 | CA2485957A1 Protease inhibitor |
| 06/17/2004 | CA2469724A1 Mutant glycoproteins |
| 06/17/2004 | CA2453387A1 Compositions and methods related to nitrotyrosine-containing compounds as antigenic agents |
| 06/16/2004 | EP1428893A2 Methods of and compositions for modulating hair growth via p-cadherin modulators |
| 06/16/2004 | EP1428891A1 Novel gene nedl-1 |
| 06/16/2004 | EP1428887A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 06/16/2004 | EP1428883A1 Megakaryocyte stimulating factors |
| 06/16/2004 | EP1428882A1 Nucleic acids showing difference in expression between hepatoblastoma anc normal liver |
| 06/16/2004 | EP1428881A1 Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same |
| 06/16/2004 | EP1428880A1 Kidney-specific urate transporter and gene thereof |
| 06/16/2004 | EP1428879A1 Polynucleotide vaccine |
| 06/16/2004 | EP1428878A1 Process for the production and purification of erythropoietin |
| 06/16/2004 | EP1428877A1 Novel protein and dna thereof |
| 06/16/2004 | EP1428870A1 Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation |
| 06/16/2004 | EP1428834A1 Ligands for flt3 receptors |
| 06/16/2004 | EP1428833A2 207 human secreted proteins |
| 06/16/2004 | EP1428832A2 Peptide and O-glycan inhibitors of selectin mediated inflammation |
| 06/16/2004 | EP1427856A2 Fusion proteins useful for detecting analytes |
| 06/16/2004 | EP1427855A2 Method and reagents for identifying gene targets for treating breast cancer |
| 06/16/2004 | EP1427841A2 Nucleic acid-associated proteins |
| 06/16/2004 | EP1427837A2 Modular transfection systems |
| 06/16/2004 | EP1427835A1 Method for purification of viral vectors having proteins which bind sialic acid |
| 06/16/2004 | EP1427833A1 Novel nucleic acid sequences and their use in methods for achieving pathogen resistance in plants |
| 06/16/2004 | EP1427831A1 Yeast membrane protein expression system and its application in drug screening |
| 06/16/2004 | EP1427830A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 06/16/2004 | EP1427829A2 Multivalent protein conjugate with multiple ligand-binding domains of receptors |
| 06/16/2004 | EP1427827A2 Synthetic hcv envelope proteins and their use for vaccination |
| 06/16/2004 | EP1427826A2 Hiv-gag codon-optimised dna vaccines |
| 06/16/2004 | EP1427825A2 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 06/16/2004 | EP1427820A2 Modified factor ix |
| 06/16/2004 | EP1427807A2 Estrogen receptor alpha variants and methods of detection thereof |
| 06/16/2004 | EP1427806A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 06/16/2004 | EP1427758A2 Compositions and methods of treating diabetes |
| 06/16/2004 | EP1427757A1 Late gestation lung genes, fragments and uses thereof |
| 06/16/2004 | EP1427756A1 Modified human growth hormone |
| 06/16/2004 | EP1427755A2 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies |
| 06/16/2004 | EP1427754A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor |
| 06/16/2004 | EP1427753A2 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications |
| 06/16/2004 | EP1427752A2 New hepatitis c virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
| 06/16/2004 | EP1427751A2 Trk polypeptide purification method |
| 06/16/2004 | EP1427750A1 Modified transferrin fusion proteins |
| 06/16/2004 | EP1427749A2 Novel proteins and nucleic acids encoding same |
| 06/16/2004 | EP1427747A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 06/16/2004 | EP1427746A2 Protein and nucleic acid expression systems |
| 06/16/2004 | EP1427745A2 Tnf receptor 2 related protein variant |
| 06/16/2004 | EP1427742A1 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof |
| 06/16/2004 | EP1427449A1 Anti-cancer agents comprising disintegrin genes and the treating methods |
| 06/16/2004 | EP1427445A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules |
| 06/16/2004 | EP1427443A1 Vaccine using papilloma virus e proteins delivered by viral vector |
| 06/16/2004 | EP1427439A1 Gamma three protease |
| 06/16/2004 | EP1427437A1 Oxyntomodulin for preventing or treating excess weight |
| 06/16/2004 | EP1427434A2 Anti-inflammatory agent |
| 06/16/2004 | EP1427426A2 Gpi-anchored cytokines |
| 06/16/2004 | EP1381864A4 Detection of candida |
| 06/16/2004 | EP1351841A4 Oil maintenance indicator |
| 06/16/2004 | EP1290142A4 Short-root gene, promoter, and uses thereof |
| 06/16/2004 | EP1278771A4 A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof |
| 06/16/2004 | EP1232176A4 Tumour suppressor factor |
| 06/16/2004 | EP1173194B1 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
| 06/16/2004 | EP1105423B1 A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders |
| 06/16/2004 | EP1071806B1 Recombinant adeno-associated viral vector encoding alpha-1-antitrypsin for gene therapy |
| 06/16/2004 | EP0881908B1 Use of fibroblast growth factors to stimulate bone growth |
| 06/16/2004 | EP0847530B1 QUANTITATION OF p97 TO DIAGNOSE AND MONITOR ALZHEIMER'S DISEASE |
| 06/16/2004 | EP0789563B1 Hepatitis virus b and c vaccines |
| 06/16/2004 | EP0787299B1 Receptor for a bacillus thuringiensis toxin |
| 06/16/2004 | EP0722333B1 Bpi-protein-products for depressed reticuloendothelial system function |
| 06/16/2004 | EP0698098B1 Method for obtaining male-sterile plants |
| 06/16/2004 | EP0692027B1 Expression of beta-2-microglobulin in pichia pastoris |
| 06/16/2004 | EP0667908B1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases |
| 06/16/2004 | EP0580737B1 Heterodimeric receptor libraries using phagemids |
| 06/16/2004 | CN1505759A Detection of candida |
| 06/16/2004 | CN1505681A A novel protein, a genes encoding therefor and a method of using the same |
| 06/16/2004 | CN1505640A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/16/2004 | CN1505639A Protein relating to restoration from cytoplasmic male sterility to fertility and gene coding the protein |
| 06/16/2004 | CN1505638A Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
| 06/16/2004 | CN1505637A Crohn's disease antibody-binding peptide and method of examining crohn's disease |
| 06/16/2004 | CN1505617A Peptides as met-ap2 inhibitors |
| 06/16/2004 | CN1505528A Immunogen comprising ligand bound hiv envelpe protein |
| 06/16/2004 | CN1505526A Compositions and methods for wt1 specific immunotherapy |
| 06/16/2004 | CN1505525A Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 06/16/2004 | CN1504581A Method for examining the risk of dental caries |
| 06/16/2004 | CN1504572A Expression of recombination FL protein in pichia yeast |
| 06/16/2004 | CN1504570A Cyclic amp receptor protein specifically combined with ª‰-acceptor excitomotor group pharmaceutical, coding gene and application thereof |
| 06/16/2004 | CN1504484A Preparing process for human serum albumin substituted by modified pig serum albumin |